Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy
Efficacy of Rose Bengal in Comparison With Toluidine Blue in Detection of Premalignant Lesions: a Preliminary Study
1 other identifier
observational
27
0 countries
N/A
Brief Summary
Abstract Objective: To study the diagnostic efficiency of Rose Bengal with Toluidine blue in detecting the biopsy sites and thus establish an accurate diagnosis in oral premalignant lesions. Materials and method: In our study 27 patients with 41 lesions were included. Since one patient had not quit the habit in the two weeks following initial examination and another lesion disappeared in the waiting period, 2 patients (3 lesions) were not included in the study. Out of 38 lesions diagnosed based on clinical criteria, 32 were leukoplakia, 5 lichen planus and 1 SCC. After initial examination they were subjected to Rose Bengal and Toluidine blue stain. If stained positive they were subjected to biopsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 14, 2016
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedResults Posted
Study results publicly available
November 5, 2018
CompletedNovember 5, 2018
March 1, 2018
1 year
December 14, 2016
February 2, 2017
March 6, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Number and Percentage of Lesions That Were Stained Positive
outcome measure1
2 weeks
Sensitivity and Specificity (Percentage of True Positives and True Negatives)
sensitivity: Percentage of lesions stained positive with Toluidine blue stain that were also stained positive with Rose Bengal stain specificity: Percentage of lesions stained negative with Toluidine blue stain that were also stained negative with Rose Bengal stain
2 weeks
Secondary Outcomes (1)
Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal
2 weeks
Study Arms (2)
Rose Bengal positive lesion and biopsy
Lesions that were stained positive with rose bengal were biopsied and assessed for dysplasia
Toluidine blue positive lesion and biopsy
Lesions that were stained positive with toluidine blue were biopsied and assessed for dysplasia
Interventions
rose bengal stain and toluidine is applied over a premalignant lesion and positively stained lesions are subjected to biopsy.
the lesions stained positive were subjected to biopsy
the lesions stained positive were subjected to biopsy
Eligibility Criteria
The study group consists of 41 oral premalignant lesions in patients visiting the Department of Oral Medicine and Radiology of The Oxford Dental College and Hospital, Bangalore.
You may qualify if:
- Patients with clinically diagnosed oral premalignant lesions (oral leukoplakia and oral lichen planus).
You may not qualify if:
- Patients with OSMF
- bleeding disorders and
- other systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Biopsy specimen of the lesion was retained.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
1. small sample size 2. only lesions stained positive were selected for biopsy procedure hence interpretation of the staining was limited to certain lesions only 3. a colorimetric guide was not used measure the intensity of staining
Results Point of Contact
- Title
- Dr. Anisha Yaji
- Organization
- The Oxford Dental college
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
December 14, 2016
First Posted
January 26, 2017
Study Start
March 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
November 5, 2018
Results First Posted
November 5, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share